Company Active LTD

Company profile

Abzena (UK) Limited

Biologics Research Partner | Dedicated Contract Development Manufacturing Organisation | Biotech Development Partner | Abzena

Abzena (UK) Limited is a UK company with status active founded in 2001 based in East of England.

CRN
04295642
Founded
2001
Age
24

Overview

Legal name
ABZENA (UK) LIMITED
Region
East of England
Registered address
BABRAHAM RESEARCH CAMPUS
BABRAHAM
CAMBRIDGE
CB22 3AT
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

2 levels 1 ultimate controller Controls 2
1
Company Active LTD
Abzena (UK) Limited
CRN 04295642
2
Direct controller Active LTD
Abzena Limited
CRN 08957107
3
Ultimate controller Active LTD
Astro Bidco Limited
CRN 11514538

Company events

Reference milestones and recent Companies House filing stream events.

9 events
02 Apr
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

19 Mar
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

20 Aug
2024

Legacy

Other

GUARANTEE2 | Transaction MzQzMjczMjA3N2FkaXF6a2N4 | Paper/PDF filed

Published 22 Aug 2024 07:11

20 Aug
2024

Accounts With Accounts Type Audit Exemption Subsiduary

Accounts PDF pending

AA | Transaction MzQzMjczMjgwOGFkaXF6a2N4 | Paper/PDF filed

Published 22 Aug 2024 07:06

20 Aug
2024

Legacy

Other

AGREEMENT2 | Transaction MzQzMjczMjMyMWFkaXF6a2N4 | Paper/PDF filed

Published 22 Aug 2024 07:06

20 Aug
2024

Legacy

Accounts PDF pending

PARENT_ACC | Transaction MzQzMjczMjQyMWFkaXF6a2N4 | Paper/PDF filed

Published 22 Aug 2024 07:06

28 Sep
2001

Incorporated

Inception

Company registered at Companies House

Public funding

5 awards
First funded
2007
Funded years
2007, 2009, 2010, 2011
Age at first award
5 years

Projects

2011 Collaborative R&D

A novel injectable sustained release delivery system for the treatment of Hepatitis C

1 Sep 2011 to 31 May 2014

Awarded
£155,793
Total cost £311,586

To address unmet clinical needs, protein-based medicines must be manufactured so as to overcome many limitations including their propensity to degrade and to clear rapidly from blood circulation. Our consortium has developed two proprietary technologies that are based on clinically proven strategies and address the inherent limitations of protein-based me...

2010 BIS-Funded Programmes Lead participant

Snovel fusion enzymes for industrial processes

1 Apr 2010 to 30 Sep 2010

Awarded
£104,700
Total cost £139,600

Awaiting Public Summary

2009 EU-Funded Lead participant

LLOT

1 Sep 2009 to 31 Oct 2011

Awarded
£132,328
Total cost £264,656

Awaiting Public Project Summary

2007 Collaborative R&D

The expression, modification and enhancement of protein therapeutics

1 Dec 2007 to 28 Feb 2010

Awarded
£136,340
Total cost £324,620

Awaiting Public Summary

2007 Collaborative R&D Lead participant

An Integrated System For Fab Bioproduction

1 Aug 2007 to 31 Jul 2009

Awarded
£351,130
Total cost £661,527

Awaiting Public Summary

Product types

BIS-Funded Programmes Collaborative R&D EU-Funded